A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost
- PMID: 19301062
- DOI: 10.1007/s10067-009-1155-6
A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost
Abstract
A single series of patients affected by systemic sclerosis (SSc) and cyclically treated with iloprost was reviewed in order to evaluate the incidence of digital ulcers (DUs) and to compare the characteristics between the patients with and without this painful and disabling vascular complication. The record charts of 85 SSc patients were revised. Ischemic DUs and scleroderma contracture ulcers were separately considered. Twenty-nine subjects developed ischemic DUs during the course of the disease; whereas, scleroderma contracture ulcers occurred in six subjects. Ischemic DUs were associated with younger age at scleroderma onset, a longer disease duration, a longer time delay from scleroderma diagnosis to iloprost therapy, a bigger skin involvement, the presence of joint contractures, a videocapillaroscopic late pattern, a history of smoking, and of corticosteroids therapy. After the exclusion of four subjects with concomitant peripheral arterial disease, a forward-stepwise logistic regression analysis showed that only four variables, i.e., age at scleroderma onset, delay in beginning iloprost therapy, history of smoking, and presence of joint contractures remained significantly associated with ischemic DUs. In a score reflecting the sum of these four risk factors, the prevalence of ischemic DUs increased progressively from the lowest to the highest value of the score. The predictivity of this model was evaluated by the receiver-operating characteristics curve, with an estimated area under the curve of 0.836 with 95% confidence interval from 0.736 to 0.937. All the patients with scleroderma contracture ulcers were characterized by both diffuse pattern of disease and positivity for anti-Scl70 antibody. In this retrospective study, scleroderma patients with ischemic DUs are characterized by early disease onset, delay in beginning iloprost therapy, smoking habit, and presence of joint contraction. A score reflecting the sum of these factors may be useful to predict the risk of developing ischemic DUs.
Similar articles
-
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.J Rheumatol. 1992 Sep;19(9):1407-14. J Rheumatol. 1992. PMID: 1279170 Clinical Trial.
-
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years.Clin Rheumatol. 2002 Jun;21(3):244-50. doi: 10.1007/pl00011223. Clin Rheumatol. 2002. PMID: 12111631
-
Long-term clinical stabilization of scleroderma patients treated with a chronic and intensive IV iloprost regimen.Rheumatol Int. 2017 Feb;37(2):245-249. doi: 10.1007/s00296-016-3582-4. Epub 2016 Oct 28. Rheumatol Int. 2017. PMID: 27796521 Free PMC article.
-
[Iloprost for the treatment of systemic sclerosis].Presse Med. 2008 May;37(5 Pt 2):831-9. doi: 10.1016/j.lpm.2007.06.016. Epub 2007 Nov 26. Presse Med. 2008. PMID: 18035518 Review. French.
-
Raynaud, digital ulcers and calcinosis in scleroderma.Reumatol Clin. 2012 Sep-Oct;8(5):270-7. doi: 10.1016/j.reuma.2012.02.006. Epub 2012 Jul 25. Reumatol Clin. 2012. PMID: 22835924 Review.
Cited by
-
Raynaud phenomenon and digital ulcers in systemic sclerosis.Nat Rev Rheumatol. 2020 Apr;16(4):208-221. doi: 10.1038/s41584-020-0386-4. Epub 2020 Feb 25. Nat Rev Rheumatol. 2020. PMID: 32099191 Review.
-
Iloprost Duration for Digital Ulcers in Systemic Sclerosis: French Retrospective Study at Two Centers and Literature Review.Front Med (Lausanne). 2022 Jul 6;9:878970. doi: 10.3389/fmed.2022.878970. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35872796 Free PMC article.
-
Assessing microvascular changes in systemic sclerosis diagnosis and management.Nat Rev Rheumatol. 2010 Oct;6(10):578-87. doi: 10.1038/nrrheum.2010.104. Epub 2010 Aug 10. Nat Rev Rheumatol. 2010. PMID: 20703220 Review.
-
Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management.Int J Clin Rheumtol. 2010;5(3):355-370. doi: 10.2217/ijr.10.17. Int J Clin Rheumtol. 2010. PMID: 26523153 Free PMC article.
-
Real life use of prostacyclin analog (iloprost), a multi-centric survey data from the Scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature.Acta Biomed. 2023 Aug 3;94(4):e2023148. doi: 10.23750/abm.v94i4.14317. Acta Biomed. 2023. PMID: 37539603 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical